Zhen-Wei Peng (Zhenwei Peng)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 12

Top Topics

Transforming Growth Factor

Chronic Kidney Disease

Helicobacter Pylori

Top Venues

Cell death & disease

Clinical and translational medicine

Hepatology international

Journal of oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Changjian Zhu, Ruilin Zheng, Xu Han, Ziwen Tang, Feng Li, Xinrong Hu, Ruoni Lin, Jiani Shen, Qiaoqiao Pei, Rong Wang, Guangyan Wei, Zhen-Wei Peng, Wei Chen, Zhou Liang, Yi Zhou
Knockout of integrin αvβ6 protects against renal inflammation in chronic kidney disease by reduction of pro-inflammatory macrophages. Cell death & disease 15 (6) (2024)
Changjian Zhu, Ruilin Zheng, Xu Han, Ziwen Tang, Feng Li, Xinrong Hu, Ruoni Lin, Jiani Shen, Qiaoqiao Pei, Rong Wang, Guangyan Wei, Zhen-Wei Peng, Wei Chen, Zhou Liang, Yi Zhou
Knockout of integrin αvβ6 protects against renal inflammation in chronic kidney disease by reduction of pro-inflammatory macrophages. Cell death & disease 15 (6) (2024)
Qin Tang, Guanghui Hu, Ye Sang, Yulu Chen, Guangyan Wei, Meiyan Zhu, Mengke Chen, Shiyong Li, Rengyun Liu, Zhen-Wei Peng
Therapeutic targeting of PLK1 in TERT promoter-mutant hepatocellular carcinoma. Clinical and translational medicine 14 (5) (2024)
Changjian Zhu, Ruilin Zheng, Xu Han, Ziwen Tang, Feng Li, Xinrong Hu, Ruoni Lin, Jiani Shen, Qiaoqiao Pei, Rong Wang, Guangyan Wei, Zhen-Wei Peng, Wei Chen, Zhou Liang, Yi Zhou
Knockout of integrin αvβ6 protects against renal inflammation in chronic kidney disease by reduction of pro-inflammatory macrophages. Cell death & disease 15 (6) (2024)
Qin Tang, Guanghui Hu, Ye Sang, Yulu Chen, Guangyan Wei, Meiyan Zhu, Mengke Chen, Shiyong Li, Rengyun Liu, Zhen-Wei Peng
Therapeutic targeting of PLK1 in TERT promoter-mutant hepatocellular carcinoma. Clinical and translational medicine 14 (5) (2024)
Changjian Zhu, Ruilin Zheng, Xu Han, Ziwen Tang, Feng Li, Xinrong Hu, Ruoni Lin, Jiani Shen, Qiaoqiao Pei, Rong Wang, Guangyan Wei, Zhen-Wei Peng, Wei Chen, Zhou Liang, Yi Zhou
Knockout of integrin αvβ6 protects against renal inflammation in chronic kidney disease by reduction of pro-inflammatory macrophages. Cell death & disease 15 (6) (2024)
Qin Tang, Guanghui Hu, Ye Sang, Yulu Chen, Guangyan Wei, Meiyan Zhu, Mengke Chen, Shiyong Li, Rengyun Liu, Zhen-Wei Peng
Therapeutic targeting of PLK1 in TERT promoter-mutant hepatocellular carcinoma. Clinical and translational medicine 14 (5) (2024)
Yuhao Tang, Zhilin Shu, Meiyan Zhu, Shuping Li, Yunyan Ling, Yizhen Fu, Zili Hu, Jiongliang Wang, Zhenyun Yang, Junbin Liao, Li Xu, Meng Yu, Zhen-Wei Peng
Size-tunable Nanoregulator-Based Radiofrequency Ablation Suppresses MDSCs And Their Compensatory Immune Evasion in Hepatocellular Carcinoma. Advanced healthcare materials (2023)
Wei Chen, Shuifang Hu, Zelong Liu, Yukun Sun, Jian Wu, Shunli Shen, Zhen-Wei Peng
Adjuvant anti-PD-1 antibody for hepatocellular carcinoma with high recurrence risks after hepatectomy. Hepatology international (2023)
Meiyan Zhu, Haonan Fan, Junlin Deng, Ke Jiang, Junbin Liao, Xiaoyue Zhang, Yong Chen, Meng Yu, Zhen-Wei Peng
BMI1 Silencing Liposomes Suppress Postradiotherapy Cancer Stemness against Radioresistant Hepatocellular Carcinoma. ACS nano (2023)
Shuifang Hu, Xiaoxue Wu, Mengchao Wei, Yunyan Ling, Meiyan Zhu, Yan Wang, Yong Chen, Meng Jin, Zhen-Wei Peng
Cost-Effectiveness Analysis of Follow-Up Schedule for Hepatocellular Carcinoma after Radiofrequency Ablation. Journal of oncology 2022 (2022)
Qun Zhang, Zhen-Wei Peng, Zhuo-Sheng Gu, Yan Wang, Fang He, Wen-Bin Zhao, Wei Luo, Yong-Yu Mei
Can Epstein-Barr virus-deoxyribonucleic acid load after induction chemotherapy combined with American Joint Committee on Cancer stage determine the chemotherapy intensity of locally advanced nasopharyngeal carcinoma? Cancer medicine (2022)